Cocoa contains many different types of physiologically active components. It was shown that cocoa beans are rich in specific antioxidants such as flavonoids, catechins, epicatechins and proanthocyanidins. Additionally, b-sitosterol, the most common phytosterol, may play a protective role in the development of cancer. The aim of this in-vitro study was to evaluate the inhibitory effect of different cocoa polyphenols extracts, alone or combined with b-sitosterol, on two human prostate cancer cell lines (nonmetastatic 22Rv1 cells and metastatic DU145 cells) and a normal human prostate cell line (RWEP-1). A synergy between b-sitosterol and cocoa polyphenols extract was also researched. Cells were treated independently with five products from 1 to 72 h: (1/) synthetic b-sitosterol, (2/) a cocoa polyphenols extract supplemented with b-sitosterol, (3/) three different cocoa polyphenols extracts naturally containing b-sitosterol. In the experiment, b-sitosterol was tested from 10 -6 to 10 -3 %; cocoa polyphenols extract supplementation was with 0.72% b-sitosterol; finally cocoa polyphenols extracts were added to the cells at very low concentrations ranging from 0.001 to 0.2%. The growth and viability of cells were measured using colorimetric assay at 1, 3, 6, 24, 48 and 72 h of treatment. IC 50 and IC 100 corresponding to the concentration leading to a decrease of 50% and 100% of cell growth were determined. At the highest tested concentration, cocoa polyphenols extracts induced a complete inhibition of growth of metastatic and nonmetastatic cancer cell lines. In addition, cocoa polyphenols extracts were more active against local cancer cells than against metastatic cells. Moreover, at the highest tested concentration, cocoa polyphenols extracts are not effective on a normal prostate cell lines. b-Sitosterol induced low growth inhibition of both cancer cell line. Cocoa polyphenols extracts, however, were significantly more active and showed a strong and fast inhibition of cell growth than b-sitosterol alone. No synergy or addition was observed when b-sitosterol was tested together with the cocoa polyphenols extract. Our results show that cocoa polyphenols extracts have an antiproliferative effect on prostate cancer cell growth but not on normal cells, at the highest tested concentration.
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Introduction
Prostate cancer is an age-dependent malignancy. Its high incidence and long latent period make it an ideal target for chemoprevention, and early lesions are generally androgen dependent. Dietary factors may influence prostate carcinogenesis and this has been proven by epidemiological studies of immigrants from Asia to the United States. The difference in mortality from prostate cancer between Japan and the United States could be partly explained by a difference in the intake of vegetables. Dietary micronutrients from vegetables have been proposed as efficient inhibitory agents for cancer initiation, progression and incidence.
Among them, polyphenols belong to a heterogeneous class of compounds, found in plant sources, with a great variety of effects. They are potent antioxidant agents acting as free radical scavengers and present antimutagenic properties (Stoner and Mukhtar, 1995; Rice-Evans et al., 1995) . Cocoa polyphenols gained attention because of their potent antioxidant properties (Ziegleder and Sandmeier, 1983; Sanbongi et al., 1998; Rein et al., 2000) and consequently their ability to reduce the concentration of reactive oxygen species in vitro (Waterhouse et al., 1996) . It can be postulated that consumption of cocoa and chocolate, adding to the available antioxidant load, would also be beneficial in decreasing the burden and efficiency of genotoxic and epigenetic carcinogens. This presumption of benefit is based on laboratory research in humans, laboratory animals and in-vitro investigations (Hertog et al., 1995; Dreosti, 2000) . The antiproliferative properties of polyphenols from cocoa extracts have been investigated on human colonic cancer cells but not on human prostate cancer cells or on normal cells. Therefore, we examined the effects of cocoa extracts containing polyphenols from different countries on prostate cancer cell (22Rv1 and DU145) and normal cell (RWEP-1) growth.
Additionally, in recent years, a great deal of attention has been given to the role of phytosterol in the protection against cancer. b-Sitosterol is the main phytosterol in the diet. Significant growth inhibition of Caco-2 human colon cancer cells (Carnesecchi et al., 2002) , LNCaP human prostate cancer cells (Von Holtz et al., 1998) and MDA-MB-231 human breast cancer cells (Awad et al., 2003) was reported by treatment with b-sitosterol. Previous studies suggest that b-sitosterol induces apoptosis in tumor cells such as breast cancer MDA-MB-231 cells and prostate cancer LNCaP cells and inhibits growth of HT-29 cells by activating the sphingomyelin cycle. No information is available regarding the effect of polyphenols combined with b-sitosterol. In this present communication, we report on such a synergistic effect.
The present in-vitro study compared the antiproliferative effects of cocoa polyphenols coming from different countries, alone or in combination with b-sitosterol, on human prostate cancer cells (DU145 and 22Rv1) and on human prostate normal cells (RWEP-1). We have compared the effect of polyphenol-containing extracts and b-sitosterol on the growth of RWEP-1, 22Rv1 and DU145 cells in a dose-time-dependent manner. Each product was applied from 1 to 72 h at different concentrations. The cell number was compared with a control, that is, cells cultured in the absence of the tested compound.
Materials and methods
Cell lines and culture conditions DU145 and 22Rv1 human prostate carcinoma cells were purchased from the American Type Culture Collection (ATCC, Rockville, Maryland, USA). DU145 cells were from a brain metastatic site and were androgen nonresponsive. 22Rv1 cells were from prostate carcinoma and were androgen-responsive. Cells were routinely maintained as monolayer cultures in 75 cm 2 flasks (Corning) at 371C in 5% CO 2 and 95% humidified atmosphere in phenol red free RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum and 1% L-glutamine. RPMI-1640, fetal bovine serum and L-glutamine were from Gibco BRL (Cergy Pontoise, France). Cell cultures were passaged every 5 days to ensure exponential growth.
RWEP-1 normal human prostate cells were purchased from the American Type Culture Collection (ATCC, Rockville, Maryland, USA). Cells were routinely maintained as monolayer culture in 75 cm 2 flasks at 371C in 5% CO 2 and 95% humidified atmosphere in keratinocyte serum-free medium supplemented with 2.5 mg of EGF human recombinant and 25 mg of bovine pituitary extract. Medium was from Gibco BRL (Cergy Pontoise, France).
Preparation of media supplemented with products
Five products were tested for this study and were stored in the dark, at + 41C. b-Sitosterol (product 1), purchased from Sigma chemicals, was initially dissolved at a final concentration of 24.1 mmol/l in absolute ethanol. Product 2, supplied by Barry Callebaut France (Meulan, France), was a defatted extract of cocoa containing 35.5% of polyphenols and 0.081% of b-sitosterol. Product 3 was reconstituted from products 1 and 2 and contained 35.5% of polyphenols and 0.72% of b-sitosterol. Products 4 and 5 were manufactured by Barry Callebaut France (Meulan, France). The composition of product 4 was unknown and it did not contain b-sitosterol. Product 5 contained 35.27% of polyphenols and 0.72% of b-sitosterol. Products 2, 3, 4 and 5 were initially dissolved in complete medium. Products 2, 4 and 5 were cocoa extracts containing polyphenols that came from different countries. From stock solutions, final concentrations of products (Table 1) used for different experiments were prepared, immediately before use, by diluting the stock solutions with complete medium. The maximum dose of b-sitosterol was 64.2 mmol/l within its solubility range and within the physiological range (4-70 mmol/l). Absolute ethanol was at a constant concentration of 0.26% in the solvent control, negative control and in all eight test concentrations. Ratios of b-sitosterol and polyphenols (Table 2) were calculated for products 2, 3 and 5. 
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Cell viability and growth assays
Cells were seeded in 96-well plates at an initial density of 15 000 cells/well for DU145, 30 000 cells/well for 22Rv1 and 25 000 cells/well for RWEP-1, with 200 ml medium per well. Cellular density was optimized according to the population doubling time of cells to obtain a significant measure of optical density and to compare results between cell lines (data not shown). After 24 h, in order to ensure uniform attachment of cells at the onset of experiments, products were added to cell culture at different concentrations and time. After incubation with products, growth and viability of cells were measured by using a Neutral Red (NR) and Sulforhodamine B (SRB) combined kit (In Cytotox, Vandoeuvre, France). The uptake of the NR vital dye into the lysosomes/endosomes and vacuoles of living cells is used as a quantitative indication of cell number and viability after treatment with a chemical test. The SRB anionic dye quantifies viable cells by measuring the protein content of cells.
Briefly, cytotoxicity was assessed 1, 3, 6, 24, 48 and 72 h after incubation of 22Rv1, RWEP-1 and DU145 cells with products. Cells were washed with 200 ml of washing solution in order to eliminate the culture medium supplemented with products. A volume of 200 ml of NR medium was added and incubated at 371C for 3 h with cells. Then, NR medium was removed and cells were washed twice with phosphate-buffered saline. Cells were fixed for 1 min with 200 ml of fixing solution. A volume of 200 ml of a desorb solution was added to extract NR from cells. After 15 min at room temperature, the optical density, which reflects the number of viable cells, was determined at 540 nm with a reference filter at 690 nm using a microplate reader (Genios, Tecan SA, France). Then, cells were washed four times with phosphatebuffered saline. Fifty microliters of 0.4% SRB solution were added to culture and 1 h later the monolayers were washed with 200 ml of rinsing solution to remove unbound dye. Then 200 ml of solubilization solution was incubated with cells to extract SRB from cells. After an overnight incubation at room temperature, the plates were read at 540 nm with a reference filter at 690 nm. Each experiment was performed three times to obtain 18 values per test condition.
Morphology
To document changes in cell morphology and growth observed during treatment, cells incubated for 48 h with the highest concentration of each product were observed ( Â 40 magnification) using phase microscopy (Leica DM IL microscope, Fisher Labosi, France) and photographed by a digital camera system (Trinitron Color Video Monitor, Fisher Labosi, France).
Results

Morphological alterations
The effect of each product on cell morphology of the three cell lines is shown in Fig. 1 . These cells were treated with the highest product concentration for up to 48 h.
In cultures of 22Rv1 cells treated with products 2, 4 and 5, the absence of adhering cells and the presence of mainly rounded cells suggested an apoptosis induction. A priori, product 3 seemed to be less efficient on 22Rv1 RWEP-1
DU145
Morphological alterations induced by b-sitosterol and/or polyphenol supplementation. RWEP-1, 22Rv1 and DU145 cells were examined for morphological changes after 2 days of treatment with product 1 (b), product 2 (c), product 3 (c), product 4 (d) and product 5 (e). (a) Cells cultured in absence of the tested products. Product 1 at 2 Â10 -2 %, product 2 at 0.2% of extract and 1.6 Â10 -4 % of b-sitosterol, product 3 at 0.2% of extract and 10 -3 % of b-sitosterol, product 4 at 0.2% of extract and product 5 at 0.2% of extract and 10 -3 % of b-sitosterol.
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cells. Although we noticed less rounded cells and we found some attached cells with a loss of morphology, there was no significant difference of density and morphology between 22Rv1 cells treated with b-sitosterol and untreated cells. We, however, observed some rounded cells on the monolayer, suggesting a very low inhibition of cell proliferation.
DU145 cells were less sensitive to treatments with products 2, 3, 4 and 5 than 22Rv1 cells. Indeed, we observed cell rounding but all cells were adherent. The number of attached cells, however, was lower with products 4 and 5 than with products 2 and 3. DU145 cells seemed to be more sensitive to products 4 and 5. b-sitosterol had no effect on the density and morphology of DU145 cells.
In cultures of RWEP-1 normal prostate cells, none of the tested products had an effect on cell morphology. In all the products, however, the number of cells decreased slightly by day 2. At the highest concentrations, products affected the growth of normal prostate cells by slowing down cell proliferation.
Inhibition of prostate cell growth in a dose-time-dependent manner
The dose-time-dependent effect of products was studied on RWEP-1, 22Rv1 and DU145 cell proliferation at percentages ranging from 1.56 Â 10 -5 to 2 Â 10 -2 % for product 1 and from 0.2 to 1.562 Â 10 -3 % for other products after 1, 3, 6, 24, 48 and 72 h of treatment (Table 1, Figs 2, 3 and 4) .
Cytotoxic effect of products on growth of normal RWEP-1 cells
Even after 72 h of treatment, the half-maximal inhibitory concentration (IC 50 ) of b-sitosterol was never reached in the range of tested concentrations. Thus, no cytotoxic effect of b-sitosterol was considered on RWEP-1 cells (data not shown). Moreover, after 48 h of treatment, the SRB assay showed a dose-dependent inhibitory effect of b-sitosterol on the normal prostate cell line. At this time, treatment with b-sitosterol caused a significant decrease in protein synthesis in RWEP-1 cells (Fig. 2) . IC 50 s of products 2, 3, 4 and 5 were not obtained after 24 h of treatment. Nevertheless, we observed a diphasic curve after 48 and 72 h of treatment. In a general way, all these products inhibited cell proliferation at concentrations ranging from 0.003125 to 0.025% of extract (Fig. 2) . No significant difference of inhibition was found between products and IC 100 s were never reached (Table 4) .
Inhibitory effects of products on growth of carcinoma 22Rv1 cells
At 1, 3 and 6 h of treatment, b-sitosterol did not inhibit lysosomial activity and protein synthesis in 22Rv1 cells. Moreover, IC 50 s were obtained at 24 and 72 h. 22Rv1 was the only cancer cell line for which the IC 50 value was obtained for b-sitosterol. It was noted that, after 48 h of treatment, a dose-dependent inhibitory effect was induced by b-sitosterol on the protein synthesis activity (Fig. 2) . Furthermore, the 22Rv1 cell line was the only one for which the IC 50 s of products 2, 3, 4 and 5 could be given after a short time of treatment (Table 3) . Thus, this cancer cell line seemed to be the most sensitive to cocoa extracts. IC 50 s at 24, 48 and 72 h of treatment with all products are presented in Table 4 . Dose-time-dependent effects are represented in Fig. 4 in order to compare the antiproliferative activity of product 2 versus 3 and product 4 versus 5. All those products presented a dose-time-dependent effect.
Inhibitory effects of products on growth of carcinoma DU145 cells
In contrast to 22Rv1 cells, b-sitosterol did not induce IC 50 s in DU145 cells, at both the short and long time of treatment. Moreover, it is noted that this phytosterol produced a dose-dependent inhibitory effect on protein synthesis activity after 48 h of treatment (Fig. 2) . Furthermore, no IC 50 was observed with products 2, 3, 4 and 5 at the short time of treatment. DU145 cells seemed to be more resistant to cocoa extracts than 22Rv1 cells. IC 50 s after 24, 48 and 72 h of treatment with all products are presented in Table 4 . Dose-time-dependent effects are represented in Fig. 3 in order to compare the antiproliferative activity of product 2 versus 3 and product 4 versus 5. All the products presented a dosetime-dependent effect, except for product 2, which presented a constant activity at all three times of treatment.
Discussion
Dietary factors may influence cancer development by altering cell signalling pathways. Polyphenols from vegetables and fruits have recently attracted increased attention because of their potent antioxidant properties. In addition, b-sitosterol may play a protective role in the development of cancer. This notion is supported by in-vivo (Raicht et al., 1980) and in-vitro (Awad et al., 1996; Downie et al., 1999) studies. To obtain information on whether polyphenols from cocoa exert a comparable effect on metastasized and nonmetastasized prostate tumors, their effect on growth of carcinoma prostate 22Rv1 and DU145 cell lines was studied in a time-dosedependent manner. Furthermore, the objective of the present in-vitro study was to examine the effects of dietary polyphenols from cocoa on the growth of normal prostate RWEP-1 cells in a time and dose-dependent manner too. Morphological and proliferation changes in these three human prostate cell lines have been observed. Our results show a direct inhibitory effect of products 2, 3, 4 and 5 on the proliferation of 22Rv1 and DU145 cell lines. It is interesting to note that the androgen-responsive 22Rv1 cells seemed to be more Effect of b-sitosterol and cocoa extracts on cell proliferation of normal human prostate and cancer cell lines. Each product was applied for 2 days (one cell cycle). Cells were seeded in 96-well plates in an initial density of 15 000 cells/well for DU145, 30 000 cells/well for 22Rv1 and 25 000 cells/well for RWEP-1 with 200 ml complete medium per well. A typical experiment in triplicate.
In-vitro effects of polyphenols from cocoa and b-sitosterol Jourdain et al. 357 sensitive to the action of cocoa extracts than the androgen-nonresponsive DU145 cells. Indeed, 22Rv1 cells were not adherent and formed aggregates in suspension whereas DU145 cells were well-attached, but we noticed a low cell number, suggesting an inhibition of cell growth. These results were confirmed by the study of cell viability and growth. According to the IC 50 s values, 22Rv1 cells were really most sensitive to the inhibitory effect of cocoa polyphenols, as compared with DU145 cells. Thus, it is interesting to note that the antiproliferative effect of polyphenols was more pronounced on the androgen-sensitive cell line (22Rv1) than on the androgen-resistant line (DU145). The difference in the sensitivity to cocoa extracts between the two tumor cell lines could be due to differences in origin of the tumor and hormone sensitivity. Indeed, 22Rv1 cells are hormone sensitive and come from prostate carcinoma. Conversely, DU145 cells are hormone-resistant and are metastatic cells. Our results, obtained from experiments performed in a dose-dependent manner, indicated that 22Rv1 prostate carcinoma cells were more sensitive to products 3 and 4 and that products 2 and 5 were the most efficient on DU145 cells growth inhibition, for 72 h of treatment. It has been reported that membranes of metastatic cells tend to have a higher fluidity than nonmetastatic tumors (Taraboletti et al., 1989) . By difference of properties, it can be surmised that the molecular mechanisms of inhibition induced by polyphenols are not the same between the two tumor cell lines. Furthermore, to explain the different inhibition profile of extracts, it can be surmised that the origin of polyphenols is very important for the efficiency of the cocoa extract. Indeed, the tested polyphenol-containing extracts came from different countries and the chemical structure of those polyphenols could be different. Thus, the antiproliferative and antitumoral efficiency of polyphenols is presumably related to their degree of polymerization (Saito et al., 1998; Mao et al., 1999) . It has been reported that the antioxidant properties of the flavanols and procyanidins present in the cocoa and Time-dose-dependent assay on DU145 cells. Cells were seeded in 96-well plates in an initial density of 15 000 cells/well. After 24 h, medium was replaced and products 2, 3, 4 and 5 were added in the culture medium. After 1, 3, 6, 24, 48 and 72 h of treatment, the neutral red cytotoxicity assay was performed on DU145 cells. IC 50 s were not obtained for the short time of treatment. Results were averaged from three separate experiments. Time-dose-dependent assay on 22Rv1 cells. Cells were seeded in 96-well plates in an initial density of 25 000 cells/well. After 24 h, the medium was replaced and products 2, 3, 4 and 5 were added to the culture medium. After 1, 3, 6, 24, 48 and 72 h of treatment, the neutral red cytotoxicity assay was performed on 22Rv1 cells. Results were averaged from three separate experiments.
chocolate can be affected by oligomeric chain length (Arteel and Sies, 1999; Lolito et al., 2000) . Thus, it would be of interest to determine the effect of oligomeric chain length on anticarcinogenic activity.
Furthermore, for RWEP-1 cells, no cytotoxic effect was observed with each product before 48 h of treatment. Our data attempted to demonstrate that the RWEP-1 normal cell line was the most resistant to all the tested products. Nevertheless, at 48 and 72 h, the results presented a diphasic curve for RWEP-1 cells incubated with cocoa extracts. At the lowest concentrations of products, there was no inhibition of cell proliferation. The more the concentration of extract increased, the stronger was the inhibition until it reached 70%. Then, the rate of inhibition decreased in spite of the increase in concentration of the extracts. Our results show an effect of cocoa polyphenols from 48 h of treatment on RWEP-1 cell proliferation, depending on the concentration used and the time of incubation. Further investigations should be performed to establish the molecular mechanism by which polyphenols inhibit the proliferation of the normal prostate cell lines.
The mechanisms of action of the cocoa polyphenols on cancer cell lines are not well-known yet. Ziegleder and Sandmeier (1983) and Sanbongi et al. (1998) have, however, demonstrated that cocoa procyanidins exhibit potent antioxidant properties and consequently reduce the concentration of reactive oxygen species. The cocoa polyphenols extracts contain important classes of antioxidant, monomeric catechins and polymeric procyanidins. In some respects, these antioxidants are similar to those present in tea, but they have distinct chemical structures and, therefore, distinct metabolic functions and attributes. The mechanisms of action of the tea polyphenols are better known than those associated with cocoa. A number of in-vitro and in-vivo studies have demonstrated that certain components of tea have potential chemopreventive effects on prostate cancer through various mechanisms including inhibition of cell growth Blot et al., 1996; Paschka et al., In-vitro effects of polyphenols from cocoa and b-sitosterol Jourdain et al. 359
1998), induction of apoptose (Ahmad et al., 1997; Paschka et al., 1998) , cell cycle arrest (Ahmad et al., 1997) , inhibition of type 2 5-a-reductase and in-vitro and in-vivo inhibition of testosteronemediated induction of ornithine decarboxylase (ODC) (Gupta et al., 1999) . In addition, Fengge et al. (2000) demonstrated that tea polyphenols had inhibitory effects on androgen action by repressing the transcription of the androgen receptor gene. The phytochemical resveratrol, which is found in grapes and wine, has been reported to have anticarcinogenic activities (Jang et al., 1997) . Damianaki et al. (2000) demonstrated the ability of resveratrol to decrease cell proliferation of hormonesensitive and resistant breast cancer cell lines in a dose and a time-dependent manner. Resveratrol accounts for more than 70% of the total polyphenols in red wine. In hormone-sensitive cell lines, a specific interaction of resveratrol with estrogen receptor was observed. According to the authors, the interaction of resveratrol with steroid receptors cannot fully explain their inhibitory effect on cell proliferation.
In this study, the mode of action of cocoa polyphenols is not established. The antioxidant properties of procyanidins extracted from cocoa have, however, been explored and demonstrated to some extent. Furthermore, Carnesecchi et al. (2002) demonstrated that flavonols and procyanidins caused nonapoptotic cell death and affected the cell cycle by causing a blockade at the G2/M phase of the cell cycle, like tea polyphenols. To explain the difference of sensitivity for androgen-responsive 22Rv1 cells and androgen-nonresponsive DU145 cells, polyphenols from cocoa will be separated, identified and their binding to androgen receptor and effects on cell cycle phases will be studied.
In conclusion, for each cocoa extract, and at the highest tested concentration, 22Rv1 and DU145 cell growth was completely inhibited, whereas growth of RWEP-1 cells was not inhibited. Furthermore, 22Rv1 cells were more sensitive to cocoa extract than DU145 cells. These results attempted to demonstrate that the polyphenols of cocoa extract had a specific anticancer activity against prostate carcinoma and metastatic cells. Furthermore, our results are the first to describe a potent antiproliferative effect of cocoa polyphenols on human prostate cancer cells. It is interesting to note that all cocoa extracts, at high concentrations, induce a complete inhibition of tumor prostatic cells without effect on normal prostatic cells. Cocoa extracts are more efficient on nonmetastatic cells than on metastatic tumors.
A greater understanding of the biological properties of cocoa polyphenols is needed before the clinical application of cocoa polyphenols as an intervention agent for prostate cancer is considered. Nonetheless, what is known so far about the actions of chocolate and cocoa products suggests that they can be considered part of a wholesome health-promoting nutritional scheme in that they add to the available antioxidants associated with other components of a disease-preventing nutritional tradition.
